Mandana Kamgar is an Oncology physician affiliated with Froedtert Hospital. OpenAlex indexes 126 publications with 1,265 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9200 W Wisconsin Ave
Milwaukee, WI 532263522
Telephone
414-805-4600Provider last certified this registry record 1 Oct 2020.
Clinical trials
- Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
Sponsor: Medical College of Wisconsin
- Determining Individualized Cancer Therapy in Pancreatic Cancer
Sponsor: Medical College of Wisconsin
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Calliditas Therapeutics US Inc.Program year20251 payment
- Astellas Pharma US IncProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
44.9%Serotonin-3 Receptor Antagonist30%Ondansetron Hcl100%Part D≥41 patientsProton pump inhibitor9.7%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Sensory organs
21.7%Corticosteroid21.7%Dexamethasone100%Part D≥22 patientsNervous system
18.8%Phenothiazine10.1%Prochlorperazine Maleate100%Part D≥16 patientsAtypical Antipsychotic8.7%Olanzapine100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Jonathon Truwit, MD
Froedtert Hospital
Ravi Dhingra, MD, MPH
Froedtert Hospital
Grant Sinson, MD
Froedtert Hospital
Keith Woeltje, MD
Froedtert Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”